Nature of Event

The document is a notice for the 7th Annual General Meeting (AGM) of Asston Pharmaceuticals Limited to be held on Tuesday, 29th September 2026 at 12:30 PM through Video Conferencing or Other Audio Visual Means.

Meeting Details and Procedures

The cut-off date for determining voting eligibility is Tuesday, 22nd September 2026. The company has arranged e-voting facilities through NSDL for members to participate. The remote e-voting period begins on Saturday, 26th September 2026 at 09:00 AM and ends on Monday, 28th September 2026 at 05:00 PM.

The registered office address is 4th Floor Office No A-431, Balaji Bhavan, Plot No 42a, Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India.

Ordinary Business Resolutions

1. Adoption of Financial Statements

  • To receive, consider and adopt the audited financial statements for the financial year ended 31st March 2026
  • Includes Balance Sheet, Statement of Profit & Loss account, cash flow statement, and Reports of Auditors and Board of Directors
  • Proposed as an Ordinary Resolution

2. Reappointment of Director

  • To appoint Mr. Ashish Narayan Sakalkar (DIN: 06601011) as Managing Director who retires by rotation
  • Proposed as an Ordinary Resolution

3. Appointment of Statutory Auditors

  • To reappoint M/s Panchal S K & Associates as statutory auditors
  • Firm Registration No. 145989W; Peer Review Certificate No. 018089
  • Term: 5 consecutive years from conclusion of 7th AGM until conclusion of 12th AGM
  • Remuneration: ₹5,00,000/- per annum plus applicable taxes and out-of-pocket expenses
  • Proposed as an Ordinary Resolution

Special Business Resolutions

4. Increase in Remuneration of Managing Director

  • Mr. Ashish Narayan Sakalkar (DIN: 06601011)
  • New remuneration: ₹6,50,000/- per month (inclusive of all components)
  • Effective from 1 October 2026 to 30 September 2029
  • Tenure as Managing Director expires on 19 September 2029
  • Entitled to reimbursement of reasonable documented business expenses
  • Proposed as a Special Resolution

5. Increase in Remuneration of Whole Time Director and CEO

  • Mrs. Saili Jayaram More (DIN: 02691527)
  • New remuneration: ₹6,50,000/- per month (inclusive of all components)
  • Effective from 1 October 2026 to 30 September 2029
  • Tenure as Whole Time Director and CEO expires on 19 September 2029
  • Entitled to reimbursement of reasonable documented business expenses
  • Proposed as a Special Resolution

6. Increase in Remuneration of Non-Executive Director

  • Mr. Sachin Chandrakant Badakh (DIN: 08685214)
  • New remuneration: ₹2,50,000/- per month (inclusive of all components)
  • Effective from 1 October 2026 to 30 September 2029
  • Entitled to reimbursement of reasonable documented business expenses
  • Proposed as a Special Resolution

Financial Performance (FY2026)

The company reported the following financial results for the year ended 31st March 2026:

  • Gross turnover including other income: ₹3158.43 lakh
  • Profit before interest, depreciation and tax: ₹555.01 lakh
  • Interest: ₹63.27 lakh
  • Depreciation: ₹32.40 lakh
  • Profit before tax: ₹459.35 lakh
  • Current tax: ₹11.30 lakh
  • Deferred tax: ₹10.56 lakh
  • Profit for the period: ₹386.52 lakh

Director Profiles and Shareholding

Mr. Ashish Narayan Sakalkar (Managing Director)

  • Age: 50 years, DIN: 06601011
  • First appointment: 16th April 2019
  • Qualifications: Diploma in Regulatory Affairs, MSc, PhD in analytical chemistry
  • Experience: Over 20 years in Industrial Chemistry, Quality Assurance, and Regulation
  • Previous remuneration: ₹3,25,000/- per month
  • Shareholding: 18,52,856 equity shares

Mrs. Saili Jayaram More (Whole Time Director and CEO)

  • Age: 56 years, DIN: 02691527
  • First appointment: 16th April 2019
  • Qualifications: BSc, Diploma in Material Management
  • Experience: Over 20 years, previously Deputy General Manager at USV Limited
  • Previous remuneration: ₹3,25,000/- per month
  • Shareholding: 18,52,856 equity shares

Mr. Sachin Chandrakant Badakh (Non-Executive Director)

  • Age: 39 years, DIN: 08685214
  • First appointment: 17th May 2024
  • Qualifications: BPharm, Diploma in Pharmacy
  • Experience: Over 10 years in pharmaceutical industry
  • Previous remuneration: ₹1,25,000/- per month
  • Shareholding: 6,06,768 equity shares

Additional Information

  • M/s Pragya & Associates, Company Secretaries, Indore appointed as Scrutinizer
  • The company's CIN is U24304MH2019PLC324187
  • No foreign investments or collaborations reported
  • The company operates in the pharmaceuticals industry